Michel Decré

Consultant in technology innovation and career, with a passion for people, innovation, and entrepreneurship.

📍 Brabantine City Row, Netherlands🔄 Updated October 2026💼 1 investments📅 6 years investing🗓 Last invested May 2020
Operator-angel🌍 Netherlands
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2020
High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology
Experience · 3 entries
All (3)
Investments (1)
Founder (2)
Board (1)
2020
Board Member
May 2020
High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology
2017
Co-Founder
Mar 2017
Salvia is a medical device company, active in the emerging field of “BioElectronics” that is inspired by biology and electronics to provide innovative therapeutic solutions. The name Salvia is derived from the Latin word salvere, which means "to stay healthy"​.​ We are driven to deliver bioelectronic solutions that restore health for people suffering from chronic migraine; our ambition is to make these novel therapies widely accessible. The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).
2011
Sapiens Steering Brain Stimulation B.V
Chief Technology Officer - Founder
Jun 2011